Senior Vice President  - Head of CMC Development Sciences

PrBIMZELX® (bimekizumab injection) approved in Canada for treatment of moderate to severe hidradenitis suppurativa (HS) Français

UCB presents positive results from GEMZ phase 3 study at AES showing fenfluramine significantly reduces countable motor seizure frequency in CDKL5 Deficiency Disorder

UCB presents positive results from GEMZ phase 3 study at AES showing fenfluramine significantly reduced countable motor seizure frequency in CDKL5 deficiency disorder

UCB shares leading scientific research and advances at American Epilepsy Society Annual Meeting

Rare Patient Experience Marketing Lead

UCB is a global biopharmaceutical company focusing on neurology and immunology. The Rare Patient Experience Marketing Lead is responsible for enhancing the patient experience by developing personalized engagement solutions and managing multi-channel marketing strategies for rare disease treatments.

0.800000011920929

Patient Experience Marketing Lead

UCB is a global biopharmaceutical company focusing on neurology and immunology. They are seeking a Rare Patient Experience Marketing Lead to enhance patient engagement and support throughout the treatment journey by developing personalized marketing solutions and collaborating with various teams.

Chief Executive Officer - General Manager

Senior Human Resources Business Partner / Associate Director Human Resources

Chiesi Announces FDA Acceptance of New Drug Application for its Triple Combination Inhaler for the Maintenance Treatment of Asthma

2025 NCS CME Symposium - Optimizing the Management of Blood Pressure in Acute Cerebrovascular Emergencies

Oak Hill Bio and Chiesi enrol first subject in BPD trial in infants

Cary headquarters plays crucial role in $160 million deal

Lead, Patient Services Marketing, Global Rare Diseases

Chiesi USA, Inc. is an international research-focused biopharmaceutical group dedicated to promoting a healthier world. The Lead, Patient Services Marketing for Rare Disease is responsible for developing and executing patient-centric marketing strategies to enhance access, engagement, and adherence for individuals with rare conditions.

Group CFO

Global Rare Diseases, Research & Development Head

Combination Inhalers Market to Grow at 6.3% CAGR Persistence Market Research

Insmed's 'blowout' Brinsupri sales beat fuels multi-blockbuster outlook

Saudi Arabia Leads Global Innovation as SFDA Issues First-Ever Pediatric Approval for Lojuxta

Chiesi licenses AbbVie subsidiary's BBB platform

Chiesi Farmaceutici is an international research-focused biopharmaceutical group dedicated to promoting a healthier world. They are seeking a Lead, Patient Services Marketing for Global Rare Diseases, responsible for developing and executing patient-centric marketing strategies that support access, engagement, and adherence for individuals living with rare conditions.

UCB is a global biopharmaceutical company focusing on neurology and immunology. The Rare Patient Experience Marketing Lead will elevate the patient experience by developing personalized engagement solutions that support treatment initiation and adherence for patients in the Rare Disease Organization.

Rare Patient Experience Marketing Lead in united states (1000+)

Rare Patient Experience Marketing Lead

Patient Experience Marketing Lead

Lead, Patient Services Marketing, Global Rare Diseases

Lead, Patient Services Marketing, Global Rare Diseases

Patient Experience Marketing Lead